DuChemBIO Co.,Ltd. (KOSDAQ:176750)
9,010.00
-50.00 (-0.55%)
At close: Apr 28, 2026
DuChemBIO Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 15,450 | 10,690 | 1,970 |
| Short-Term Investments | - | - | 11.06 |
| Cash & Short-Term Investments | 15,450 | 10,690 | 1,981 |
| Cash Growth | 44.52% | 439.69% | - |
| Accounts Receivable | 11,819 | 9,650 | 8,330 |
| Other Receivables | 301.76 | 530.51 | 773.01 |
| Receivables | 12,121 | 10,181 | 9,103 |
| Inventory | 1,038 | 1,304 | 1,307 |
| Prepaid Expenses | 65.23 | 17.3 | 22.96 |
| Other Current Assets | 284.41 | 47.47 | 254.36 |
| Total Current Assets | 28,957 | 22,240 | 12,668 |
| Property, Plant & Equipment | 22,954 | 16,712 | 16,186 |
| Long-Term Investments | 3,381 | 3,339 | 2,125 |
| Goodwill | 10,108 | 10,108 | 10,108 |
| Other Intangible Assets | 7,755 | 8,725 | 7,281 |
| Long-Term Accounts Receivable | 269.5 | 398.07 | - |
| Long-Term Deferred Tax Assets | 2,909 | 2,562 | - |
| Other Long-Term Assets | 1,341 | 1,085 | 659.66 |
| Total Assets | 77,676 | 65,168 | 49,277 |
| Accounts Payable | 1,044 | 1,183 | 1,276 |
| Accrued Expenses | 280.55 | 19.07 | 15.69 |
| Short-Term Debt | 4,014 | 3,614 | 8,240 |
| Current Portion of Long-Term Debt | 2,743 | 4,343 | 3,943 |
| Current Portion of Leases | 7,647 | 3,028 | 2,543 |
| Current Income Taxes Payable | 277.11 | 100 | 92.17 |
| Other Current Liabilities | 2,376 | 2,637 | 3,248 |
| Total Current Liabilities | 18,381 | 14,925 | 19,357 |
| Long-Term Debt | - | - | 1,200 |
| Long-Term Leases | 10,055 | 6,566 | 5,830 |
| Pension & Post-Retirement Benefits | - | 668.11 | 1,095 |
| Other Long-Term Liabilities | 0 | - | 0 |
| Total Liabilities | 28,436 | 22,159 | 27,482 |
| Common Stock | 14,603 | 14,603 | 13,513 |
| Additional Paid-In Capital | 18,270 | 18,270 | 7,424 |
| Retained Earnings | 17,097 | 10,925 | 2,958 |
| Treasury Stock | -1,165 | -1,165 | -2,887 |
| Comprehensive Income & Other | 435.29 | 376.64 | 411.86 |
| Total Common Equity | 49,240 | 43,010 | 21,419 |
| Shareholders' Equity | 49,240 | 43,010 | 21,794 |
| Total Liabilities & Equity | 77,676 | 65,168 | 49,277 |
| Total Debt | 24,459 | 17,551 | 21,755 |
| Net Cash (Debt) | -9,009 | -6,861 | -19,775 |
| Net Cash Per Share | -317.09 | -255.39 | -739.20 |
| Filing Date Shares Outstanding | 28.34 | 28.34 | 26.75 |
| Total Common Shares Outstanding | 28.34 | 28.34 | 26.75 |
| Working Capital | 10,576 | 7,315 | -6,689 |
| Book Value Per Share | 1737.18 | 1517.38 | 800.68 |
| Tangible Book Value | 31,377 | 24,176 | 4,031 |
| Tangible Book Value Per Share | 1106.97 | 852.94 | 150.67 |
| Machinery | 50,786 | 50,127 | 49,396 |
| Construction In Progress | 300.69 | 103.5 | 396.35 |
Source: S&P Capital IQ. Standard template. Financial Sources.